Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001559053-25-000023
Filing Date
2025-05-08
Accepted
2025-05-08 16:15:12
Documents
67
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q prta-20250331.htm   iXBRL 10-Q 1167212
2 EX-31.1 prta2025q110-qxex311.htm EX-31.1 11070
3 EX-31.2 prta2025q110-qxex312.htm EX-31.2 11183
4 EX-32.1 prta2025q110-qxex321.htm EX-32.1 9087
  Complete submission text file 0001559053-25-000023.txt   6586927

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prta-20250331.xsd EX-101.SCH 68755
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prta-20250331_cal.xml EX-101.CAL 72912
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prta-20250331_def.xml EX-101.DEF 301401
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prta-20250331_lab.xml EX-101.LAB 747025
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prta-20250331_pre.xml EX-101.PRE 500344
70 EXTRACTED XBRL INSTANCE DOCUMENT prta-20250331_htm.xml XML 613866
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Filer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35676 | Film No.: 25926297
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)